HCA Healthcare, Inc. $HCA Shares Sold by Fideuram Intesa Sanpaolo Private Banking S.P.A.

Fideuram Intesa Sanpaolo Private Banking S.P.A. trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 23.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,999 shares of the company’s stock after selling 2,778 shares during the quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A.’s holdings in HCA Healthcare were worth $4,259,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Nordea Investment Management AB lifted its holdings in HCA Healthcare by 11.2% in the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after acquiring an additional 108,849 shares during the last quarter. Nomura Asset Management Co. Ltd. increased its position in HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after buying an additional 3,724 shares during the period. Hudson Bay Capital Management LP boosted its holdings in shares of HCA Healthcare by 154.5% during the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after acquiring an additional 2,849 shares during the period. Advisors Capital Management LLC grew its position in shares of HCA Healthcare by 61.5% during the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after acquiring an additional 2,604 shares during the last quarter. Finally, CWA Asset Management Group LLC lifted its position in HCA Healthcare by 1,062.4% in the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock valued at $4,461,000 after purchasing an additional 8,733 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of HCA opened at $409.99 on Friday. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The company has a 50-day moving average of $400.65 and a two-hundred day moving average of $462.43. The stock has a market cap of $90.95 billion, a price-to-earnings ratio of 14.10, a PEG ratio of 1.30 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the company posted $6.45 EPS. The firm’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

Analyst Ratings Changes

Several research firms recently commented on HCA. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Weiss Ratings lowered shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Stephens dropped their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Truist Financial set a $413.00 price target on HCA Healthcare in a research note on Thursday, June 4th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $503.00.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.